The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study
| Image |  |
|---|---|
| Description | scholarly article by Ewa Janczewska et al published 16 November 2018 in BMC Infectious Diseases |
| Author/s | |
| Publication date | November 16, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |